Base Therapeutics announces the completion of its A2 round of financing
Base Therapeutics' AccuBase® Base Editor Receives Overseas Patent Authorization HONG KONG SAR - Media Outreach Newswire - 12 September 2024 - Base Therapeutics recently announced the completion of its A2 round financing, raising tens of millions of RMB. This round of financing was led by AEF Greater Bay Area Fund, managed by Gobi Partners GBA and will be used to strengthen Base Therapeutics' R&D t...
read full article
